Outcomes research collaborations between third-party payers, academia, and pharmaceutical manufacturers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Outcomes research collaborations between third-party payers, academia, and pharmaceutical manufacturers

Published:2006-06 Issue:2 Volume:7 Page:129-136
ISSN:1618-7598
Container-title:The European Journal of Health Economics
language:en
Short-container-title:Eur J Health Econ

Author:

Eichler Hans-Georg,Kong Sheldon X.,Grégoire Jean-Pierre

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Economics, Econometrics and Finance (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1007/s10198-006-0345-2.pdf

Reference36 articles.

1. Liberati A, Magrini N (2003) Information from drug companies and opinion leaders. BMJ 326:1156–1157

2. Morgan S, Barer M, Evans R (2000) Health economists meet the fourth tempter: drug dependency and scientific discourse. Health Econ 9:659–667

3. Crowley WF, Sherwood L, Salber P, Scheinberg D, Slavkin H, Tilson H, Reece EA, Catanese V, Johnson SB, Dobs A, Genel M, Korn A, Reame N, Bonow R, Grebb J, Rimoin D (2004) Clinical research in the United States at a crossroads: proposal for a novel public-private partnership to establish a National Clinical Research Enterprise. JAMA 291:1120–1126

4. Anis AH, Gagnon Y (2000) Using economic evaluations to make formulary coverage decisions. Pharmacoeconomics 18:55–62

5. Edmonds P, Glynn D, Oglialoro C (2000) Access to important new medicines. Eur Business J 12:146–157

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The needs, challenges, and opportunities from the academic researchers' perspective;Essentials of Translational Pediatric Drug Development;2024

2. Health Research Collaborations by Academic Entities: A Systematic Review;Academic Medicine;2023-05-26

3. Views from Academia, Industry, Regulatory Agencies, and the Legal System;Textbook of Pharmacoepidemiology;2021-11-15

4. Managing conflicts of interest at the European Medicines Agency;Conflict of Interest and Medicine;2021-07-20

5. Pharmacoepidemiology and the Law;Pharmacoepidemiology;2019-10-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3